Skip to main content
Top
Published in: Cancer Cell International 1/2020

Open Access 01-12-2020 | Correction

Correction to: Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma

Authors: Wanqing Weng, Zhongjing Zhang, Weiguo Huang, Xiangxiang Xu, Boda Wu, Tingbo Ye, Yunfeng Shan, Keqing Shi, Zhuo Lin

Published in: Cancer Cell International | Issue 1/2020

Login to get access

Excerpt

Following publication of the original article [1], the authors notified us that Fig. 6 was incorrectly submitted. The correct figure is presented below.
Metadata
Title
Correction to: Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma
Authors
Wanqing Weng
Zhongjing Zhang
Weiguo Huang
Xiangxiang Xu
Boda Wu
Tingbo Ye
Yunfeng Shan
Keqing Shi
Zhuo Lin
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2020
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-020-01381-x

Other articles of this Issue 1/2020

Cancer Cell International 1/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine